logo

Blyth Inc (BTH)



Trade BTH now with
  Date
  Headline
2/18/2020 9:02:36 AM Bigtincan Partners With NTT DOCOMO
12/3/2018 7:03:05 AM Nash Reports Positive Pre-Clinical Results For Its Lead Compound NP-178 In A New Study For Crohn’s Disease
11/13/2018 7:02:17 AM Nash Pharma Announces Positive Pre-Clinical Results For NP-178 In Inflammatory Bowel Disease
11/1/2018 7:14:28 AM Nash Pharma Announces Positive Pre-Clinical Results For NP-160
10/22/2018 7:02:22 AM Breathtec Announces Acquisition Of Nash Pharmaceuticals
9/25/2018 11:01:13 AM Bigtincan Acquires FatStax
6/18/2018 9:30:50 AM Bigtincan Acquires Zunos
5/3/2018 10:58:34 AM Bigtincan Names John Moore VP Of Customer Success
4/4/2018 9:04:45 AM Bigtincan Announces Several Executive Additions And Promotions
3/1/2018 9:04:16 AM Breathtec Biomedical Appoints Christopher Moreau As CEO Effective March 1, 2018
11/1/2013 8:08:47 AM Blyth Inc (BTH) Has Lowered Its 2013 EPS Estimate To 0.35 - 0.45 From 0.75 - 0.90
8/2/2013 8:37:04 AM Blyth Inc (BTH) Has Lowered Its 2013 EPS Estimate To 0.75 - 0.90 From 1.30 - 1.45
5/8/2013 8:10:52 AM Blyth Inc (BTH) Has Lowered Its FY13 EPS Estimate To 1.30 - 1.45 From 1.70 - 1.85
11/6/2012 6:58:45 PM Blyth Inc (BTH) Has Lowered Its FY12 EPS Estimate To 2.28 - 2.43 From 2.47 - 2.62
8/3/2012 8:09:05 AM Blyth Inc (BTH) Has Raised Its 2012 EPS Estimate To 3.00 - 3.15 From 2.75 - 2.88
5/16/2012 4:03:05 PM Blyth Inc (BTH) Declares 2 For 1 Stock Split
5/4/2012 8:08:48 AM Blyth Inc (BTH) Has Raised Its 2012 EPS Estimate To 5.50 - 5.75 From 5.00 - 5.25
11/17/2011 10:11:55 AM Blyth Inc (BTH) Declares Special Dividend of $ 1.50, Record Date 12/1/2011
9/6/2011 8:33:55 AM Blyth Inc (BTH) Has Raised Its 2012 EPS Estimate To 2.23 - 2.43 From 2.10 - 2.30
6/3/2011 8:39:17 AM Blyth Inc (BTH) Has Lowered Its FY 12 EPS Estimate To 2.10 - 2.30 From 2.80 - 3.00